Skip to main content
Updating results

Dose

  • Updated

GENEVA (AP) — The World Health Organization gave emergency use authorization Friday to a COVID-19 vaccine manufactured by China's Sinopharm, potentially paving the way for millions of the doses to reach needy countries through a U.N.-backed program rolling out coronavirus vaccines.

  • Updated

WASHINGTON (AP) — The U.S. Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine for youngsters ages 12 to 15 by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year.

  • Updated

A U.S. health panel says it’s time to resume use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots. Out of nearly 8 million people vaccinated before the U.S. suspended J&J’s shot, health officials uncovered 15 cases of a highly unusual kind of blood clot, three of them fatal. All were women, most younger than 50.

  • Updated

The Baltimore factory hired to help make Johnson & Johnson’s COVID-19 vaccine was dirty, didn’t follow proper manufacturing procedures and had poorly trained staff, resulting in contamination of material going into a batch of shots, U.S. regulators said Wednesday.

  • Updated

LONDON (AP) — The European Union’s drug regulatory agency said Tuesday that it found a “possible link” between Johnson & Johnson’s COVID-19 vaccine and extremely rare blood clots and recommended a warning be added to the label. But experts at the agency reiterated that the vaccine’s benefits outweigh the risks.

  • Updated

JOHANNESBURG (AP) — South Africa's decision to suspend the use of the Johnson & Johnson vaccine due to preliminary reports of rare blood clots has left the country without any shots as it struggles to combat an aggressive coronavirus variant.

  • Updated

BARCELONA, Spain (AP) — European countries diverged Wednesday on whether they would push ahead with giving their residents Johnson & Johnson's COVID-19 vaccine after reports of very rare blood clots in a handful of recipients in the United States.

  • Updated

JOHANNESBURG (AP) — South Africa suspended giving Johnson & Johnson vaccine shots Tuesday as a “precautionary measure” and the company delayed its European vaccine rollout following an FDA decision to pause the jabs while very rare blood clot cases are examined.

Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Breaking News

Crime

Entertainment & Dining

Latest News

Local Sports

NWI Prep Sport News

Weather Alerts